| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |